Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study
- 1 February 2010
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (4), 667-674
- https://doi.org/10.1200/jco.2009.21.8032
Abstract
Purpose Preemptive strategies in neutropenic patients based on serum galactomannan (GM) –guided triggering of diagnostic work-up may be time-consuming and expensive when applied to the entire popul...Keywords
This publication has 23 references indexed in Scilit:
- New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patientsBest Practice & Research Clinical Haematology, 2007
- Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic AdjunctsClinical Infectious Diseases, 2007
- Invasive AspergillosisDrugs, 2007
- Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?European Journal of Haematology, 2006
- Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infectionSupportive Care in Cancer, 2006
- Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility StudyClinical Infectious Diseases, 2005
- Perspectives for the management of febrile neutropenic patients with cancer in the 21st centuryCancer, 2005
- Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatmentThe Lancet Oncology, 2003
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Persistent Fever in Patients with NeutropeniaNew England Journal of Medicine, 2002